ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HCM Hutchmed (china) Limited

304.00
8.00 (2.70%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  8.00 2.70% 304.00 303.00 305.00 310.00 300.00 306.00 204,831 16:35:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 838M 100.78M - N/A 0
Hutchmed (china) Limited is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchmed (china) was 296p. Over the last year, Hutchmed (china) shares have traded in a share price range of 173.60p to 338.00p.

Hutchmed (china) currently has 871,256,270 shares in issue.

Hutchmed (china) Share Discussion Threads

Showing 1551 to 1573 of 4100 messages
Chat Pages: Latest  68  67  66  65  64  63  62  61  60  59  58  57  Older
DateSubjectAuthorDiscuss
19/6/2018
08:03
Then collapsed 8% overnight, what an up and down ride it is at the moment, pending news.
mad foetus
15/6/2018
21:40
Bots went mad and then a $5m+ trade came in. Bodes well
mad foetus
15/6/2018
21:25
SP up 3.34% in US market today, despite tariff news and general market decline.
nimrod22
15/6/2018
08:05
news due:-

1. First NDA + Milestone payment from Lilly
2. 2nd Property compensation
3. Commencement of Savolitinib Phase 3 NSCLC + Milestone payment from AZ
4. Lilly decision on taking global ex-China rights to Fruquintinib

Let's hope Lilly don't take up global rights to Fruquintinib. We can then use our new U.S. Regulatory Team to liaise directly with the FDA, complete the caucasian bridging study then launch in the U.S on our own for $$$$

nerdofsteel
14/6/2018
01:50
Hope you are not surprised then! ;-)

Just needs some news that we know is due and hopefully £50 will be left in the rear-view mirror. Whatever happens to the economies of the world China and the health of its citizens, in the main when it comes to HCM, will still continue.

lauders
12/6/2018
15:40
Tongue in cheek, but will be surprised if it doesn't reach £50 in the near future
nimrod22
12/6/2018
15:07
You were expecting more nimrod22? Why? If you don't mind me asking. That has been a pretty quick recovery from the quick dip!
lauders
12/6/2018
10:30
I'm a bit puzzled as to why its only up 17.8% in the last three days !!
nimrod22
10/6/2018
07:57
hmmmm those share options prior to the first NDA is a great move by the Management - NDA expected probably Q3 but could come at any time to surprise the market
nerdofsteel
08/6/2018
17:35
cyclical is better, its on the way up!!
nimrod22
08/6/2018
15:39
I'm old and a tad cynical!
steeplejack
08/6/2018
15:31
On the move, now up 9.5% and 5% in USA. Its quite possible that there's some big share buys/sells which will not be reported until Monday
nimrod22
08/6/2018
15:03
SP up 4% in UK and 2% in USA, if it keeps this up on Monday then I'd suggest that its in a cycle back up mode for the next three weeks and worth buying in at this depressed price.
nimrod22
07/6/2018
14:47
Options given, brakes off? Surely not!
mad foetus
07/6/2018
14:20
Luckily,management have been awarded new options at a strike price that reflects recent share price weakness.Every cloud has a silver lining.
steeplejack
05/6/2018
16:03
Volume really picking up the last couple of weeks. Pity the price has been going down!
mad foetus
05/6/2018
15:42
Interesting Report just published on China Biotech

hxxps://www.lek.com/sites/default/files/insights/pdf-attachments/biopharma-international-expansion-china.pdf

nerdofsteel
05/6/2018
14:02
Thank you nerdofsteel
gswredland
05/6/2018
13:06
gswredland4 Jun '18 - 08:40 - 1478 of 1482

Yes, Mark has been invested for over 10 years, but has unfortunately had to make partial disposals many times in order to avoid breaking the 10% stake size in his Growth Fund.

It's been a great problem for him to have and I have no doubt the problem will continue to occur over the next decade.

It's been his largest holding for a long time, currently makes up 8.66% of his Growth Fund, and that's after a recent large disposal.

hxxp://www.slaterinvestments.com/media/108554/slater_growth_fund_a_-_fact_sheet_april_2018.pdf

nerdofsteel
04/6/2018
15:06
sp moved quite strongly in to the oversold on the RSI graph. Up in the US market today and probably about to turn in the UK market
nimrod22
04/6/2018
14:35
Thanks Lauders
gswredland
04/6/2018
13:38
You could say that gswredland:

Don't think anything has been sold other than when it went above 10% of portfolio value and then it had to be for balancing. Think that is correct.

What's up with today's share price action? Good news and negative. Should have released it as an RNS and not RNSNON! Perhaps the US market will appreciate it?

lauders
04/6/2018
08:40
Hi guys
So Mark Slater is big here?

gswredland
Chat Pages: Latest  68  67  66  65  64  63  62  61  60  59  58  57  Older

Your Recent History

Delayed Upgrade Clock